Nevertheless, our findings provide basis for optimism that PrP lowering may be a promising therapeutic strategy, both for prophylaxis against prion disease onset in at-risk individuals with no evidence of disease process underway (43,44), and for treatment of active prion disease, during either prodromal or manifest disease. Here, PRNP is linked to prion disease.